Personal Capital Advisors Corp acquired a new stake in Masimo Co. (NASDAQ:MASI) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,013 shares of the medical equipment provider’s stock, valued at approximately $251,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. United Services Automobile Association boosted its stake in shares of Masimo by 0.7% in the second quarter. United Services Automobile Association now owns 71,510 shares of the medical equipment provider’s stock valued at $6,983,000 after purchasing an additional 485 shares during the period. US Bancorp DE boosted its stake in shares of Masimo by 36.9% in the second quarter. US Bancorp DE now owns 1,980 shares of the medical equipment provider’s stock valued at $193,000 after purchasing an additional 534 shares during the period. Oregon Public Employees Retirement Fund boosted its stake in shares of Masimo by 3.0% in the second quarter. Oregon Public Employees Retirement Fund now owns 18,628 shares of the medical equipment provider’s stock valued at $1,819,000 after purchasing an additional 535 shares during the period. Janney Capital Management LLC boosted its stake in shares of Masimo by 11.2% in the second quarter. Janney Capital Management LLC now owns 6,115 shares of the medical equipment provider’s stock valued at $597,000 after purchasing an additional 614 shares during the period. Finally, Profund Advisors LLC boosted its stake in shares of Masimo by 13.2% in the first quarter. Profund Advisors LLC now owns 8,118 shares of the medical equipment provider’s stock valued at $714,000 after purchasing an additional 946 shares during the period. 83.25% of the stock is owned by institutional investors and hedge funds.

A number of brokerages recently issued reports on MASI. Stifel Nicolaus lifted their price target on shares of Masimo from $108.00 to $112.00 and gave the stock a “buy” rating in a research note on Thursday, August 2nd. Needham & Company LLC began coverage on shares of Masimo in a research note on Friday, September 14th. They issued a “buy” rating for the company. BidaskClub upgraded shares of Masimo from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 17th. Zacks Investment Research upgraded shares of Masimo from a “hold” rating to a “buy” rating and set a $110.00 price target for the company in a research note on Tuesday, July 3rd. Finally, ValuEngine upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research note on Monday, July 2nd. Two analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $109.20.

Shares of Masimo stock opened at $117.13 on Friday. Masimo Co. has a 52-week low of $80.69 and a 52-week high of $126.89. The company has a market capitalization of $6.45 billion, a P/E ratio of 47.81, a PEG ratio of 2.91 and a beta of 1.00.

Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Wednesday, August 1st. The medical equipment provider reported $0.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.02. Masimo had a net margin of 15.30% and a return on equity of 21.49%. The company had revenue of $211.62 million during the quarter, compared to the consensus estimate of $207.85 million. During the same quarter in the previous year, the firm earned $0.83 earnings per share. The firm’s quarterly revenue was up 10.0% on a year-over-year basis. As a group, equities research analysts forecast that Masimo Co. will post 2.9 EPS for the current fiscal year.

In other news, insider Ramshorst David J. Van sold 1,325 shares of the business’s stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $125.00, for a total transaction of $165,625.00. Following the completion of the sale, the insider now owns 2,325 shares in the company, valued at approximately $290,625. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Sanford Fitch sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 1st. The stock was sold at an average price of $101.00, for a total transaction of $202,000.00. Following the sale, the director now owns 57,832 shares of the company’s stock, valued at approximately $5,841,032. The disclosure for this sale can be found here. Insiders have sold a total of 765,380 shares of company stock valued at $90,720,456 in the last 90 days. Insiders own 12.60% of the company’s stock.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Story: Closed-End Mutual Funds (CEFs)

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.